patient clinical study treatment trial disease drug subject event therapy risk reported hospital outcome diagnosis related analysis cancer month site year organ follow following 
result blood dialysis included heart using use 
dose case mortality 
considered medication medical 
table data death compared diabetes group pet based baseline associated diagnostic time guideline cohort laboratory use used 
procedure clinical_trial treated high adverse protocol type mortality acute versus without used day performed infection symptom age indication received one however population low transplant phase imaging cardiac kidney surgery admission surgical discharge randomized efficacy increased expected survival post pre rate following stage primary additional disorder medical difference due cardiovascular renal assessed 
